Is your organization’s funding and time better used in pursuit of scientific breakthroughs, or infrastructure? Mispro offers state-of-the-art vivarium research facilities for preclinical in vivo drug development, available to biopharmaceutical companies of all sizes.
Companies are now empowered to keep early-stage preclinical in vivo studies in-house. Operating within the contract vivarium (CV) model offers the control and flexibility biotech startups need to increase productivity while removing infrastructure headaches, allowing them to focus on data validation, good science, and basic efficacy, particularly in point-of-contact (POC) studies.
The contract vivarium model is the most strategically sound and risk-averse option for early-stage biotech startups conducting preclinical rodent studies, by removing the costs and operational complexities of staffing, compliance, and insurance - so your organization can focus solely on science.
Mispro’s fully-equipped turnkey animal research facilities are AAALAC-accredited, and accessible to multiple companies for in vivo preclinical R&D, typically with rodents. By providing a fully equipped, managed, and staffed space for research, the CV model offers biotechs a high quality, high-potential strategy for early-stage drug development.
“Running an in vivo research program is complex, time-consuming and expensive,” said Dr. Keith Astrofsky, DVM, Director of Operations at Mispro. “With our insource offering, Mispro provides the people, infrastructure, and know-how to run vivarium research facilities in a safe, humane, and compliant manner, giving back considerable time and resources to client companies so they can focus instead on their drug development programs.”
Experience the new preclinical landscape. Complete the form below for information about Mispro Biotech.
Mispro is an AAALAC-accredited organization committed to providing best-in-class laboratory animal services and regulatory compliance oversight for your preclinical research. To ensure safety and compliance at all times in our research facilities, we require that every study conducted in our vivarium facilities is approved by our in-house Institutional Animal Care and Use Committee (IACUC). Mispro strictly follows regulatory guidelines for the ethical and humane treatment of research animals.
Our state-of-the-art research environments focus on quality, compliance, and consistency, leading to more accurate data and faster results. Take the first step in de-risking your preclinical studies.
Choosing to conduct studies in a contract vivarium cansignificantly reduce the initial investment needed to launch in vivo work, enabling biotech startupteams to start small and scale when they’re ready. When trials fail, teams cannimbly scale down and reallocate resources. Conversely, projects can expand quickly when data supportsfurther inquiry. This agility provides organizations greater flexibility acrossthe lifecycle of their development program, enabling them to budget fundingdollars proportionately on validating early-stage studies, then allocateremaining funds or seek additional funds for results-based growth.
Choose the vivarium facility nearest you